Type 2 Diabetes

Showing NaN - NaN of 69

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes Trial in Worldwide (Orforglipron, Semaglutide)

Not yet recruiting
  • Type 2 Diabetes
  • Phoenix, Arizona
  • +135 more
Sep 13, 2023

Type 2 Diabetes Trial in Worldwide (Orforglipron, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Sheffield, Alabama
  • +91 more
Jul 25, 2023

Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • +3 more
  • Los Angeles, California
  • +91 more
Jul 10, 2023

Obesity, Overweight, Type 2 Diabetes Trial in Worldwide (Orforglipron, Placebo)

Not yet recruiting
  • Obesity
  • +2 more
  • Pelham, Alabama
  • +135 more
May 15, 2023

Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • +5 more
  • Muscle Shoals, Alabama
  • +320 more
Apr 12, 2023

Colorectal Cancer, Type 2 Diabetes Trial in Los Angeles (Intervention Group (IG))

Not yet recruiting
  • Colorectal Cancer
  • Type 2 Diabetes
  • Intervention Group (IG)
  • Los Angeles, California
    Charles R. Drew University
Mar 10, 2023

Type 2 Diabetes, T2D Trial in Worldwide (LY3209590, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • T2D
  • Birmingham, Alabama
  • +71 more
Jan 26, 2023

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Lispro (U100), Insulin Glargine (U100))

Completed
  • Type 2 Diabetes
  • Sheffield, Alabama
  • +134 more
Nov 22, 2022

Pediatric Obesity, Type 2 Diabetes, Time Restricted Eating Trial in Los Angeles (Time Limited Eating, Components Common to All

Not yet recruiting
  • Pediatric Obesity
  • +2 more
  • Time Limited Eating
  • +3 more
  • Los Angeles, California
    Children's Hospital of Los Angeles
Nov 15, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Antihyperglycemic medication)

Not yet recruiting
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +96 more
Aug 8, 2022

Type 2 Diabetes Trial in Worldwide (Dulaglutide, Placebo)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +60 more
Jun 7, 2022

Type 2 Diabetes Trial in Worldwide (LY3502970, Dulaglutide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • Anaheim, California
  • +43 more
Jun 21, 2022

Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Birmingham, Alabama
  • +74 more
Apr 18, 2022

Type 2 Diabetes Trial in Worldwide (Mylan's insulin glargine, LantusĀ®)

Completed
  • Type 2 Diabetes
  • Chandler, Arizona
  • +119 more
Mar 1, 2022

Type 2 Diabetes Trial in Australia, China, United States (INS068 injection, Insulin Degludec)

Active, not recruiting
  • Type 2 Diabetes
  • INS068 injection
  • Insulin Degludec
  • Huntington Park, California
  • +32 more
Jan 27, 2022

TODAY2 Phase 2 Follow-up

Completed
  • Type 2 Diabetes
  • TODAY cohort
  • Los Angeles, California
  • +14 more
Jul 29, 2021

TODAY Genetics Study

Completed
  • Type 2 Diabetes
    • Little Rock, Arkansas
    • +24 more
    Jul 28, 2021

    Type 2 Diabetes Trial in United States (Tirzepatide, Placebo)

    Completed
    • Type 2 Diabetes
    • Fresno, California
    • +12 more
    Apr 28, 2021

    Type 2 Diabetes Trial in United States (Rivoglitazone, Pioglitazone, Placebo)

    Completed
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +73 more
    May 6, 2021

    Type 2 Diabetes Trial in Worldwide (Placebo, Exenatide)

    Completed
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +52 more
    Nov 6, 2020

    Type 2 Diabetes, Obesity Trial in Los Angeles, London Village (Sugar-reduction intervention)

    Completed
    • Type 2 Diabetes
    • Obesity
    • Sugar-reduction intervention
    • Los Angeles, California
    • +1 more
    Mar 24, 2020

    Hyperuricemia, Albuminuria, Type 2 Diabetes Trial in United States (Verinurad 9 mg+Febuxostat 80 mg, Placebo)

    Completed
    • Hyperuricemia
    • +2 more
    • Verinurad 9 mg+Febuxostat 80 mg
    • Placebo
    • Canyon Country, California
    • +17 more
    Dec 18, 2019

    Prediabetes, Type 2 Diabetes, Obesity Trial in Los Angeles (Metformin, gastric banding)

    Completed
    • Prediabetes
    • +2 more
    • Los Angeles, California
      University of Southern California
    Oct 15, 2019

    Type 2 Diabetes Trial in Los Angeles (Liraglutide)

    Withdrawn
    • Type 2 Diabetes
    • Los Angeles, California
      Cedars Sinai Medical Center
    Sep 26, 2019

    Type 2 Diabetes Trial in Worldwide (Dulaglutide, Placebo)

    Completed
    • Type 2 Diabetes
    • Glendale, California
    • +65 more
    Sep 5, 2019